financetom
Business
financetom
/
Business
/
Expion360 to Raise $2.6 Million From Securities Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Expion360 to Raise $2.6 Million From Securities Offering
Jan 2, 2025 11:05 AM

01:43 PM EST, 01/02/2025 (MT Newswires) -- Expion360 ( XPON ) said Thursday that it has struck deals to sell its securities to institutional investors to raise about $2.6 million for general corporate purposes and working capital.

The transactions consisted of the sale of about 1.05 million shares, or pre-funded warrants, each of which will be sold together with one warrant to buy one share per warrant at an exercise price of $2.36, the company said.

The offering price per share is $2.48, the firm said. It expects to close the transactions Friday.

Price: 2.33, Change: -0.06, Percent Change: -2.51

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ANI Pharmaceuticals Says FDA Approves Expanded Label for Iluvien
ANI Pharmaceuticals Says FDA Approves Expanded Label for Iluvien
Mar 14, 2025
07:22 AM EDT, 03/14/2025 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) said Friday that the US Food and Drug Administration has now approved Iluvien to treat chronic non-infectious uveitis affecting the eye's posterior segment. The company intends to market the implant for chronic NIU-PS in addition to its current indication of diabetic macular edema in the US. ANI shares...
BMO on The Day Ahead in Canada
BMO on The Day Ahead in Canada
Mar 14, 2025
07:21 AM EDT, 03/14/2025 (MT Newswires) -- On the data docket for Canada at 8:30 a.m. ET Friday are manufacturers' shipments and wholesale trade both for January, said Bank of Montreal (BMO). They are expected to spike around 2% month over month in January, partly in anticipation of United States tariffs, noted the bank. New motor vehicle sales look to...
Eton's Diabetes Drug Candidate Passes Bioequivalence Study
Eton's Diabetes Drug Candidate Passes Bioequivalence Study
Mar 14, 2025
07:20 AM EDT, 03/14/2025 (MT Newswires) -- Eton Pharmaceuticals ( ETON ) said Friday a bioequivalence study of its product candidate ET-600 showed pharmacokinetic equivalence to the U.S. Food and Drug Administration (FDA)-approved reference product of the same active ingredient. ET-600 is an oral solution of desmopressin under development for the treatment of central diabetes insipidus. Eton said it expects...
Why Is Poultry Producer Pilgrim's Pride Stock Surging Today?
Why Is Poultry Producer Pilgrim's Pride Stock Surging Today?
Mar 14, 2025
Food company Pilgrim’s Pride Corporation shares are trading higher in premarket on Friday. The company has introduced a capital allocation strategy designed to strengthen its financial position, broaden its diverse portfolio, and generate long-term value for its shareholders. As a component of this initiative, the board has approved a special cash dividend of $6.30 per share. With the current share...
Copyright 2023-2026 - www.financetom.com All Rights Reserved